Article

Critically ill COVID-19 status associated trait genetics reveals CDK6 inhibitors as potential treatment

2021-06-04

Abstract excerpt

<title>Abstract</title> <p>Despite the recent development of vaccines and monoclonal antibodies preventing SARS-CoV-2 infection, treating critically ill COVID-19 patients still remains a top goal. In principle, drug repurposing – the use of an already existing drug for a new indication – could provide a shortcut to a treatment. However, drug repurposing is often very speculative due to lack of clinical evidence....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 123d68c1-d508-5e4c-9899-3e251812c840
DOI: 10.21203/rs.3.rs-568366/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Critically ill COVID-19 status associated trait genetics reveals CDK6 inhibitors as potential treatmentDOI 10.21203/rs.3.rs-568366/v1Read

High neutrophils and triglycerides lead to critical illness in COVID-19 and reveal CDK6 inhibitors as potential treatmentSemantic proximity Read

Neutrophils cause critical illness in COVID-19 and reveal CDK6 inhibitors as potential treatmentSemantic proximity Read

Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 TreatmentSemantic proximity Read

Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approachSemantic proximity Read

COVID-19: A Drug Repurposing and Biomarker Identification by Using Comprehensive Gene-Disease Associations through Protein-Protein Interaction Network AnalysisSemantic proximity Read

A genetically based computational drug repurposing framework for rapid identification of candidate compounds: application to COVID-19Semantic proximity Read

Safeguarding COVID-19 and cancer management: drug design and therapeutic approachSemantic proximity Read

Drug Repurposing of potential drug targets for treatment of COVID-19Semantic proximity Read

Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19Semantic proximity Read

IL10RB as a key regulator of COVID-19 host susceptibility and severitySemantic proximity Read

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19Semantic proximity Read

Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe CasesSemantic proximity Read